0001683168-23-008824.txt : 20231213
0001683168-23-008824.hdr.sgml : 20231213
20231213173008
ACCESSION NUMBER: 0001683168-23-008824
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231211
FILED AS OF DATE: 20231213
DATE AS OF CHANGE: 20231213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EISENBERG JEFFREY F
CENTRAL INDEX KEY: 0001224096
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37937
FILM NUMBER: 231485056
MAIL ADDRESS:
STREET 1: 99 HAYDEN AVENUE, SUITE 230
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xenetic Biosciences, Inc.
CENTRAL INDEX KEY: 0001534525
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452952962
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 945 CONCORD ST.
CITY: FRAMINGHAM
STATE: MA
ZIP: 01701
BUSINESS PHONE: 781-778-7720
MAIL ADDRESS:
STREET 1: 945 CONCORD ST.
CITY: FRAMINGHAM
STATE: MA
ZIP: 01701
FORMER COMPANY:
FORMER CONFORMED NAME: General Sales & Leasing, Inc.
DATE OF NAME CHANGE: 20130227
FORMER COMPANY:
FORMER CONFORMED NAME: GENERAL AIRCRAFT INC.
DATE OF NAME CHANGE: 20111108
4
1
ownership.xml
X0508
4
2023-12-11
0
0001534525
Xenetic Biosciences, Inc.
XBIO
0001224096
EISENBERG JEFFREY F
945 CONCORD STREET
FRAMINGHAM
MA
01701
1
1
0
0
Chief Executive Officer
0
Stock Options
3.88
2023-12-11
4
A
0
20000
0
A
2033-12-11
Common Stock
20000
20000
D
The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of December 11, 2023; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on March 11, 2025 and ending on December 11, 2026.
/s/ Jeffrey F. Eisenberg
2023-12-13